Bench-to-bedside development of multifunctional flexible embolic agents
Dawei Wang1,2,3, Wei Rao1,2,3
1Key Lab of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
Advanced embolic materials enhance transarterial chemoembolization (TACE) for liver cancer (HCC). This review covers new micro/nano materials and liquid metal agents, improving TACE efficacy and patient outcomes.
Area of Science:
- Biomaterials Science
- Interventional Radiology
- Oncology
Background:
- Transarterial chemoembolization (TACE) offers survival benefits for unresectable hepatocellular carcinoma (HCC).
- Conventional TACE has limitations including side effects, limited efficacy, and narrow indications.
- Emerging particulate embolic agents aim to overcome these limitations.
Purpose of the Study:
- To provide a comprehensive overview of current and emerging micro/nano particulate embolization materials for TACE.
- To highlight the features, functions, and applications of these advanced materials.
- To discuss novel liquid metal-based embolic agents and future directions.
Main Methods:
- Systematic review of recent literature on micro/nano materials for TACE.
- Identification and description of typical features, functions, and applications.
- Analysis of liquid metals as advanced embolic agents.
Main Results:
- Micro/nano particulate embolic agents offer improved degradability, drug delivery, detectability, and targetability.
- Liquid metal-based agents present multifunctional and flexible embolic properties.
- Various materials show promise for enhanced tumor response and reduced complications.
Conclusions:
- Emerging micro/nano materials and liquid metal agents represent significant advancements in TACE technology.
- These novel embolic agents hold potential to improve treatment outcomes for HCC patients.
- Further research and development in material science are crucial for optimizing TACE therapy.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
12:27Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
